All In Biotech

Free tool

FAERS Monitor: Diovan

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021283 or its brand name (Diovan, Valsartan). Reports on generic versions are filed under their own applications.

Reports

105,697

Serious

80,579

76% of reports

Hospitalization

39,667

Death reported

9,601

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective6,427
  • fatigue5,691
  • dizziness5,453
  • dyspnoea5,406
  • nausea5,312
  • diarrhoea4,778
  • headache4,671
  • hypertension4,393
  • blood pressure increased4,307
  • pain3,901
  • fall3,690
  • asthenia3,686
  • malaise3,654
  • acute kidney injury3,314
  • off label use3,168

Reports by year received

View as table
YearReports
20041,626
20052,193
20062,550
20072,616
20082,697
20093,818
20104,607
20115,852
20125,748
20134,926
20145,417
20156,320
20166,084
20175,890
20188,380
20196,939
20205,330
20214,715
20224,408
20233,921
20244,235
20254,198
20263,216

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,948,462 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
blood pressure increasedSignal4,3075.75.616,496
acute kidney injurySignal3,3144.44.28,523
hypertensionSignal4,3934.24.110,566
fallSignal3,6902.22.22,484
dizzinessSignal5,4532.22.13,565
asthenia3,6862.01.91,747
dyspnoea5,4061.91.92,381
malaise3,6541.71.6978
headache4,6711.51.4759
diarrhoea4,7781.51.4752
fatigue5,6911.51.4843
nausea5,3121.31.3467
pain3,9011.31.2222
drug ineffective6,4271.00.96
off label use3,1680.70.7362

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.